New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 23, 2013
10:09 EDTSUNS, SNA, UTHR, WDAY, EAGL, FIS, NFBK, FTK, QLGC, FISV, AVGO, PBF, STRZA, HRG, ELX, ALLTOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: Allot Communications (ALLT) initiated with an Overweight at Barclays... Avago (AVGO) initiated with an Outperform at RBC Capital... Emulex (ELX) initiated with a Neutral at Piper Jaffray... FIS (FIS) initiated with a Buy at UBS... Fiserv (FISV) initiated with a Neutral at UBS... Global Eagle Acquisition (EAGL) initiated with an Outperform at Imperial Capital... Harbinger Group (HRG) initiated with a Buy at Jefferies... Mellanox (MLNX) initiated with an Overweight at Piper Jaffray... QLogic (QLGC) initiated with a Neutral at Piper Jaffray... Starz (STRZA) initiated with a Neutral at ISI Group... Workday (WDAY) initiated with a Neutral at RW Baird... Flotek (FTK) initiated with an Outperform at Barrington... United Therapeutics (UTHR) initiated with a Neutral at Guggenheim... PBF Energy (PBF) initiated with a Neutral at Citigroup... Northfield Bancorp (NFBK) initiated with a Buy at Sterne Agee... Solar Senior Capital (SUNS) initiated with a Buy at Maxim... Snap-On (SNA) initiated with a Neutral at Sidoti.
News For ALLT;AVGO;FIS;ELX;FISV;EAGL;HRG;QLGC;WDAY;STRZA;FTK;UTHR;PBF;NFBK;SUNS;SNA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
December 18, 2014
05:49 EDTALLTAllot Communications initiated with a Hold at Jefferies
Subscribe for More Information
December 17, 2014
10:02 EDTQLGCOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Google (GOOG) upgraded to Buy from Hold at Pivotal Research... Twitter (TWTR) upgraded to Buy from Hold at Pivotal Research... Aaron's (AAN) upgraded to Buy from Hold at KeyBanc... Calpine (CPN) upgraded to Buy from Hold at Deutsche Bank... Check Point (CHKP) upgraded to Buy from Hold at Deutsche Bank... Columbia Sportswear (COLM) upgraded to Buy from Neutral at Goldman... Dakota Plains Holdings (DAKP) upgraded to Buy from Hold at Canaccord... SunCoke Energy (SXC) upgraded to Outperform from Neutral at Credit Suisse... Taylor Morrison (TMHC) upgraded to Buy from Hold at Evercore ISI... Teck Resources (TCK) upgraded to Buy from Neutral at UBS... VeriFone (PAY) upgraded to Overweight from Equal Weight at Barclays... Motorola Solutions (MSI) upgraded to Buy from Hold at Argus... Approach Resources (AREX) upgraded to Neutral from Reduce at Global Hunter... HealthSouth (HLS) upgraded to Outperform from Market Perform at Raymond James... QLogic (QLGC) upgraded to Overweight from Equal Weight at Morgan Stanley... Baker Hughes (BHI) upgraded to Focus List from Outperform at Howard Weil... Kansas City Southern (KSU) upgraded to Overweight from Equal Weight at Stephens... BlackBerry (BBRY) upgraded to Buy from Hold at BGC Financial.
08:25 EDTQLGCQLogic upgraded to Overweight from Equal Weight at Morgan Stanley
Subscribe for More Information
07:19 EDTPBFIndependent Refiners sector cut to Market Weight at Wells Fargo
Subscribe for More Information
06:11 EDTUTHRUnited Therapeutics changes CEO compensation structure
Subscribe for More Information
06:09 EDTUTHRUnited Therapeutics names Roger Jeffs co-CEO and David Zaccardelli as COO
United Therapeutics announced two senior executive promotions: Roger Jeffs has been promoted to President and Co-CEO and David Zaccardelli to Executive VP and COO. CEO Rothblatt's title will change to Chairman and Co-CEO. As Chairman of the Board and Co-CEO, Rothblatt will continue to serve as the principal executive officer of the company. These title changes will become effective January 1, 2015. Jeffs joined United Therapeutics in 1998 and currently serves as the company's President and COO since 2001. Zaccardelli currently serves as Chief Manufacturing Officer and EVP, Pharmaceutical Development, a position he has held since 2008.
December 16, 2014
07:41 EDTAVGOSome semconductor names to benefit from LTE, auto strength, says Oppenheimer
Subscribe for More Information
December 15, 2014
06:58 EDTPBFPBF Energy downgraded to Underperform from Neutral at BofA/Merrill
BofA/Merrill downgraded PBF Energy to Underperform due to the lower oil price environment and risks of over supply from new global refinery capacity in the Atlantic basin. Price target lowered to $26 from $31.
December 12, 2014
06:41 EDTWDAYWorkday resumed with a Neutral at Piper Jaffray
Price target raised to $87 from $83.
December 11, 2014
10:13 EDTUTHROn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: ARIAD (ARIA) downgraded at Credit Suisse... AbbVie (ABBV) downgraded to Equal Weight from Overweight at Morgan Stanley... Aimco (AIV) downgraded to Hold from Buy at KeyBanc... Anglo American (AAUKY) downgraded to Underperform from Neutral at Exane BNP Paribas... Approach Resources (AREX) downgraded at Sterne Agee... CommVault (CVLT) downgraded to Neutral from Outperform at Macquarie... Fifth Street Senior (FSFR) downgraded to Perform from Outperform at Oppenheimer... Harmonic (HLIT) downgraded to Neutral from Buy at Sidoti... Macerich (MAC) downgraded to Hold from Buy at Deutsche Bank... Newell Rubbermaid (NWL) downgraded to Outperform from Strong Buy at Raymond James... Olin Corp. (OLN) downgraded at Longbow... Penn West (PWE) downgraded to Underperform from Neutral at BofA/Merrill... Prudential plc (PUK) downgraded to Neutral from Buy at Nomura... Semiconductor Manufacturing (SMI) downgraded to Hold from Buy at Jefferies... Suncor (SU) downgraded to Neutral from Buy at BofA/Merrill... Talisman Energy (TLM) downgraded to Underperform from Neutral at BofA/Merrill... Thompson Creek (TC) downgraded to Hold from Buy at Deutsche Bank... Toll Brothers (TOL) downgraded to Underperform from Sector Perform at RBC Capital... Travelers (TRV) downgraded to Neutral from Buy at UBS... United Therapeutics (UTHR) downgraded at Credit Suisse... Vera Bradley (VRA) downgraded to Underperform from Neutral at Sterne Agee.
08:21 EDTUTHRUnited Therapeutics downgraded at Credit Suisse
As previously reported, Credit Suisse downgraded United Therapeutics to Underperform from Neutral. The analyst has increased concerns regarding long-term competitive threats for the PAH franchise based on Remodulin's patent expiration in October 2017 and the launch of ATLN's Selexipag in 2016. Price target raised to $120 from $100.
06:35 EDTUTHRUnited Therapeutics downgraded to Underperform from Neutral at Credit Suisse
December 10, 2014
10:00 EDTALLTOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:23 EDTALLTOn The Fly: Pre-market Movers
Subscribe for More Information
08:07 EDTALLTAllot Communications downgraded at BofA/Merrill
Subscribe for More Information
06:51 EDTALLTAllot Communications downgraded to Underperform from Buy at BofA/Merrill
Subscribe for More Information
December 9, 2014
08:45 EDTPBFSnow Capital Management reports 5.2% passive stake in PBF Energy
Subscribe for More Information
08:06 EDTAVGOAvago announces 35c per share interim dividend
Subscribe for More Information
07:32 EDTSTRZAUBS to hold a conference
Subscribe for More Information
December 7, 2014
17:43 EDTHRGRadioShack looks to amend terms of loan from Salus, Bloomberg says
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use